Effects of pharmaconutrients on cellular dysfunction and the microcirculation in critical illness

Current Opinion in Anaesthesiology

Volumn 22, Issue 2, 2009, Pages 177-183

  Weitzel, Lindsay Rae B ^a,b   Mayles, William J ^a   Sandoval, Paul A ^a   Wischmeyer, Paul E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Research Complex 2   (United States)

Author keywords

3 fatty acids; Antioxidants; Arginine; Glutamine; Vitamin C

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; CD59 ANTIGEN; DOCOSAHEXAENOIC ACID; FISH OIL; GLUTAMINE; GLYCERYL TRINITRATE; HEAT SHOCK PROTEIN; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OROTATE MAGNESIUM; PLACEBO; SELENIUM; THIOCTIC ACID; UBIDECARENONE; ZINC;

ACUTE DISEASE; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; BURN; CELL METABOLISM; CELL PROTECTION; CLINICAL TRIAL; COLITIS; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DRUG MEGADOSE; HEART FUNCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MICROCIRCULATION; NONHUMAN; NUTRIENT MANAGEMENT; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SELENIUM DEFICIENCY; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; ARGININE; ASCORBIC ACID; CELLS; CRITICAL ILLNESS; FATTY ACIDS, OMEGA-3; GLUTAMINE; HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; MICROCIRCULATION; MICRONUTRIENTS; SELENIUM; ZINC;

EID: 68049104251     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328328d32f     Document Type: Review

References (94)

1. Newsholme EA, Crabtree B, Ardawi MS. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol 1985; 70:473-489.
2. Wilmore DW. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 2001; 131 (9 Suppl):2543S-2549S; discussion 2550S-2541S.
3. Wischmeyer PE. Glutamine and heat shock protein expression. Nutrition 2002; 18:225-228.
4. Morrison AL, Dinges M, Singleton KD, et al. Glutamine's protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol 2006; 290:C1625-C1632.
5. Wischmeyer PE. Glutamine: the first clinically relevant pharmacological regulator of heat shock protein expression? Curr Opin Clin Nutr Metab Care 2006; 9:201-206.
6. Pelham HR. Speculations on the functions of the major heat shock and glucose-regulated proteins. Cell 1986; 46:959-961.
7. Marber MS, Mestril R, Chi SH, et al. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 1995; 95:1446-1456.
8. Villar J, Edelson JD, Post M, et al. Induction of heat stress proteins is associated with decreased mortality in an animal model of acute lung injury. Am Rev Respir Dis 1993; 147:177-181.
9. Lappas GD, Karl IE, Hotchkiss RS. Effect of ethanol and sodium arsenite on HSP-72 formation and on survival in a murine endotoxin model. Shock 1994; 2:34-39; discussion 40.
10. Villar J, Ribeiro SP, Mullen JB, et al. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med 1994; 22:914-921.
11. Wischmeyer PE, Musch MW, Madonna MB, et al. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol 1997; 272 (4 Pt 1):G879-G884.
12. Ziegler TR, Ogden LG, Singleton KD, et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005; 31:1079-1086.
13. Singleton KD, Serkova N, Banerjee A, et al. Glutamine attenuates endotoxin-induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70. Nutrition 2005; 21:214-223.
14. Singleton KD, Wischmeyer PE. Oral glutamine enhances heat shock protein expression and improves survival following hyperthermia. Shock 2006; 25:295-299.
15. Wischmeyer PE, Kahana M, Wolfson R, et al. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 2001; 90:2403-2410.
16. Wischmeyer PE, Kahana M, Wolfson R, et al. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001; 16:398-402.
17. Wischmeyer PE, Riehm J, Singleton KD, et al. Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition 2003; 19:1-6.
18. Wischmeyer PE, Vanden Hoek TL, Li C, et al. Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr 2003; 27:116-122.
19. Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med 2005; 33:1206-1213.
20. Wischmeyer PE, Jayakar D, Williams U, et al. Single dose of glutamine preserves myocardial tissue metabolism, glutathione content, and enhances myocardial function following ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr 2003; 27:396-403.
21. Fan J, Li Y, Levy RM, et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 2007; 178:6573-6580.
22. Szijarto A, Hahn O, Batmunkh E, et al. Short-term alanyl-glutamine dipeptide pretreatment in liver ischemia-reperfusion model: effects on microcirculation and antioxidant status in rats. Clin Nutr 2007; 26:640-648. This study showed that GLN treatment can support the microcirculation and protect against liver necrosis and I/R injury in the rat model.
23. Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003; 6:223-228.
24. Popovic PJ, Zeh HJ 3rd, Ochoa JB. Arginine and immunity. J Nutr 2007; 137 (6 Suppl 2):1681S-1686S.
25. This review highlights recent data on the effects of arginine on the immune system, including the specifics of T cells, cytokines, and myeloid-suppressing cells.
26. Luiking YC, Deutz NE. Exogenous arginine in sepsis. Crit Care Med 2007; 35 (9 Suppl):S557-S563. This is an up-to-date and well written review on the possible role of arginine supplementation in septic humans.
27. Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007; 109:1568-1573.
28. Makarenkova VP, Bansal V, Matta BM, et al. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006; 176:2085-2094.
29. Rodriguez PC, Zea AH, DeSalvo J, et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol 2003; 171:1232-1239.
30. Bronte V, Serafini P, Mazzoni A, et al. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003; 24:302-306.
31. Bernard AC, Mistry SK, Morris SM Jr, et al. Alterations in arginine metabolic enzymes in trauma. Shock 2001; 15:215-219.
32. Ochoa JB, Bernard AC, O'Brien WE, et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg 2001; 233:393-399.
33. Tsuei BJ, Bernard AC, Shane MD, et al. Surgery induces human mononuclear cell arginase I expression. J Trauma 2001; 51:497-502.
34. Waitzberg DL, Saito H, Plank LD, et al. Postsurgical infections are reduced with specialized nutrition support. World J Surg 2006; 30:1592-1604.
35. Morris SM Jr. Arginine: beyond protein. Am J Clin Nutr 2006; 83:508S-512S.
36. Chiarla C, Giovannini I, Siegel JH. Plasma arginine correlations in trauma and sepsis. Amino Acids 2006; 30:81-86.
37. Mehta S, Stewart DJ, Levy RD. The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans. Chest 1996; 109:1550-1555.
38. Castejon AM, Hoffmann IS, Jimenez E, et al. Differential blood pressure effects of oral glucose and intravenous L-arginine in healthy lean normotensive and obese hypertensive subjects. J Hum Hypertens 2002; 16 (Suppl 1):S133-S136.
39. Fink MP. Modulating the L-arginine-nitric oxide pathway in septic shock: choosing the proper point of attack. Crit Care Med 1999; 27:2019-2022.
40. Pastor C, Teisseire B, Vicaut E, Payen D. Effects of L-arginine and L-nitroarginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 1994; 22:465-469.
41. Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30.
42. Parker JL, Myers PR, Zhong Q, et al. Inhibition of endothelium-dependent vasodilation by Escherichia coli endotoxemia. Shock 1994; 2:451-458.
43. Myers PR, Zhong Q, Jones JJ, et al. Release of EDRF and NO in ex vivo perfused aorta: inhibition by in vivo E. coli endotoxemia. Am J Physiol 1995; 268 (3 Pt 2):H955-H961.
44. Spronk PE, Ince C, Gardien MJ, et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360:1395-1396.
45. Kalil AC, Sevransky JE, Myers DE, et al. Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock. Crit Care Med 2006; 34:2719-2728.
46. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008; 233:674-688. Comprehensive review of historical and modern importance of ω-6:ω-3 fatty acid ratio in diet. Excellent discussion of role of excessive ω-6 intake and deficient ω-3 fat intake in industrialized world's diet leading to rapid increase in diabetes and cardiovascular disease.
47. Pontes-Arruda A, Demichele S, Seth A, Singer P. The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr 2008; 32:596-605. This meta-analysis showed that ventilated patients with ALI/ARDS experienced significant reduction in mortality and improvements in oxygenation and clinical outcomes when fed diets enriched with EPA and γ-linolenic acid.
48. Singer P, Shapiro H, Theilla M, et al. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 2008; 34:1580-1592. This review discusses the specific effects of EPA/DHA (and molecules derived from them) on the immune system, the inflammatory response, and even vagal tone.
49. Pluess TT, Hayoz D, Berger MM, et al. Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 2007; 33:789-797. This study showed that fish oil treatment could blunt the usual response to lipopolysaccharide in healthy individuals.
50. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007; 28:176-183. This study reviews recent data on the role of resolvins and protectins (derived from EPA and DHA) in controlling the magnitude and duration of inflammation.
51. Weber PC, Fischer S, von Schacky C, et al. The conversion of dietary eicosapentaenoic acid to prostanoids and leukotrienes in man. Prog Lipid Res 1986; 25:273-276.
52. Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 2006; 75:197-202.
53. Shimizu T, Igarashi J, Ohtuka Y, et al. Effects of n-3 polyunsaturated fatty acids and vitamin E on colonic mucosal leukotriene generation, lipid peroxidation, and microcirculation in rats with experimental colitis. Digestion 2001; 63:49-54.
54. Pscheidl E, Schywalsky M, Tschaikowsky K, Boke-Prols T. Fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med 2000; 28:1489-1496.
55. El-Badry AM, Moritz W, Contaldo C, et al. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology 2007; 45:855-863. Mouse model of hepatic I/R injury showing v-3 fatty acid pretreatment can preserve microvascular flow following injury.
56. Bruckner G. Microcirculation, vitamin E and omega 3 fatty acids: an overview. Adv Exp Med Biol 1997; 415:195-208.
57. Heyland DK, Dhaliwal R, Day AG, et al. REducing Deaths due to OXidative Stress (The REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 2006; 65:250-263.
58. Biesalski HK, McGregor GP. Antioxidant therapy in critical care - is the microcirculation the primary target? Crit Care Med 2007; 35 (9 Suppl): S577-S583. This review highlights the effects of supraphysiologic doses of vitamin C on nitric oxide bioavailability and the endothelium and microcirculation in sepsis.
59. Crimi E, Ignarro LJ, Napoli C. Microcirculation and oxidative stress. Free Radic Res 2007; 41:1364-1375. This review discusses the role that oxidative stress plays in inflammatory pathways and in the microcirculation in disease.
60. Collier BR, Giladi A, Dossett LA, et al. Impact of high-dose antioxidants on outcomes in acutely injured patients. JPEN J Parenter Enteral Nutr 2008; 32:384-388. This was a retrospective cohort study evaluating a 387-day high-dose antioxidant diet in acutely injured patients in over 384 000 patients. The high-dose antioxidant protocol resulted in a 328% relative risk reduction in mortality and decreased hospital and ICU length of stay.
61. Long CL, Maull KI, Krishnan RS, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003; 109:144-148.
62. Metnitz PG, Bartens C, Fischer M, et al. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25:180-185.
63. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236:814-822.
64. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 1996; 93:3704-3709.
65. del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44:2737-2745.
66. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996; 94:6-9.
67. Rossig L, Hoffmann J, Hugel B, et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 2001; 104:2182-2187.
68. May JM. How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 2000; 28:1421-1429.
69. Baker TA, Milstien S, Katusic ZS. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 2001; 37:333-338.
70. Carr A, Frei B. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med 2000; 28:1806-1814.
71. Armour J, Tyml K, Lidington D, Wilson JX. Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol 2001; 90:795-803.
72. Wu F, Tyml K, Wilson JX. Ascorbate inhibits iNOS expression in endotoxin- and IFN gamma-stimulated rat skeletal muscle endothelial cells. FEBS Lett 2002; 520:122-126.
73. Nualart FJ, Rivas CI, Montecinos VP, et al. Recycling of vitamin C by a bystander effect. J Biol Chem 2003; 278:10128-10133.
74. Tyml K, Li F, Wilson JX. Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit Care Med 2008; 36:2355-2362. This study showed that ascorbate can reverse capillary blood flow impairment in septic skeletal muscle through an eNOS-dependent mechanism.
75. Tyml K, Li F, Wilson JX. Delayed ascorbate bolus protects against maldistribution of microvascular blood flow in septic rat skeletal muscle. Crit Care Med 2005; 33:1823-1828.
76. Wu F, Schuster DP, Tyml K, Wilson JX. Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells. Free Radic Biol Med 2007; 42:124-131. This study used cells to show that ascorbate regulates NADPH oxidases in microvascular endothelial cells in a septic environment, thus blocking the production of reactive oxygen species that cause endothelial dysfunction.
77. Tanaka H, Matsuda T, Miyagantani Y, et al. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study. Arch Surg 2000; 135:326-331.
78. Rayman MP. The importance of selenium to human health. Lancet 2000; 356:233-241.
79. Zapletal C, Heyne S, Breitkreutz R, et al. The influence of selenium substitution on microcirculation and glutathione metabolism after warm liver ischemia/reperfusion in a rat model. Microvasc Res 2008; 76:104-109. This study used a rat model to show that selenium substitution could protect the animal from I/R injury by scavenging radicals and by preserving the liver's own antioxidative capacity.
80. Beckett GJ, Arthur JR. Selenium and endocrine systems. J Endocrinol 2005; 184:455-465.
81. Venardos K, Harrison G, Headrick J, Perkins A. Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion. J Trace Elem Med Biol 2004; 18:81-88.
82. Tirosh O, Levy E, Reifen R. High selenium diet protects against TNBS-induced acute inflammation, mitochondrial dysfunction, and secondary necrosis in rat colon. Nutrition 2007; 23:878-886. Rodent model of colitis showing selenium therapy can preserve cellular and mitochondrial function following inflammatory injury
83. Angstwurm MW, Engelmann L, Zimmermann T, et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007; 35:118-126. This randomized, placebo-controlled, multicenter trial of 249 patients with severe SIRS, sepsis, and septic shock determined that treating these patients with selenium reduced mortality rate.
84. Heyland DK, Jones N, Cvijanovich NZ, Wong H. Zinc supplementation in critically ill patients: a key pharmaconutrient? JPEN J Parenter Enteral Nutr 2008; 32:509-519. This study discusses the role of zinc supplementation as a therapeutic agent in the critically ill and conducts a systematic review of the current randomized trials related to zinc in critical care. It concludes that zinc supplementation is associated with only a nonsignificant reduction in mortality and length of stay. The study also calls for more trials to determine the correct dose of zinc and to elucidate its efficacy in the critically ill.
85. Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr 2003; 133 (5 Suppl 1):1460S-1462S.
86. Ho E, Courtemanche C, Ames BN. Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J Nutr 2003; 133:2543-2548.
87. Frederickson CJ, Maret W, Cuajungco MP. Zinc and excitotoxic brain injury: a new model. Neuroscientist 2004; 10:18-25.
88. Liuzzi JP, Lichten LA, Rivera S, et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A 2005; 102:6843-6848.
89. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 1998; 17:109-115.
90. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 2004; 24:277-298.
91. Failla ML. Trace elements and host defense: recent advances and continuing challenges. J Nutr 2003; 133 (5 Suppl 1):1443S-1447S.
92. Prasad AS. Zinc: mechanisms of host defense. J Nutr 2007; 137:1345-1349.
93. King LE, Osati-Ashtiani F, Fraker PJ. Apoptosis plays a distinct role in the loss of precursor lymphocytes during zinc deficiency in mice. J Nutr 2002; 132: 974-979.
94. Pepe S, Leong JY, Merwe JV, et al. Targeting oxidative stress in surgery: effects of ageing and therapy. Exp Gerontol 2008; 43:653-657. This study is a review of results pertaining to targeted oxidative therapies and their effect on recovery from cardiac surgery. It also includes physical and mental therapies in cardiac surgery patients.